Impax Announces Availability of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg

EMVERM Provides a New Option for Patients with Pinworm, Whipworm, Roundworm and Hookworm in Single or Mixed Infections HAYWARD, Calif., April 13, 2016 -- (Healthcare Sales & Marketing Network) -- Impax Laboratories, Inc. (IPXL)today announced that EMVE... Biopharmaceuticals, Product LaunchImpax Laboratories, EMVERM, mebendazole
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news